Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma

• Published in: The Journal of infection Vol. 80; no. 4; pp. 454 - 461
• Main Authors: Butcher, Robert, Handley, Becca, Garae, Mackline, Taoaba, Raebwebwe, Pickering, Harry, Bong, Annie, Sokana, Oliver, Burton, Matthew J, Sepúlveda, Nuno, Cama, Ana, Mesurier, Richard Le, Solomon, Anthony W., Mabey, David, Taleo, Fasihah, Tekeraoi, Rabebe, Roberts, Chrissy h
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.04.2020; W.B. Saunders
• Subjects: Aged; Anti-Bacterial Agents - therapeutic use; Anti-Pgp3 antibodies; Child; Child, Preschool; Chlamydia trachomatis; Cicatrix - drug therapy; Cicatrix - epidemiology; Humans; Infant; Kiribati; Micronesia; Neglected tropical diseases; Trachoma; Trachoma - drug therapy; Trachoma - epidemiology; Vanuatu; Vanuatu; Micronesia; Neglected tropical diseases; Trachoma; Vanuatu; Chlamydia trachomatis; Kiribati; Anti-Pgp3 antibodies

•In Vanuatu, ocular Chlamydia infection prevalence is low; in Kiribati it is high.•In Vanuatu, Pgp3 seroprevalence does not increase in childhood; in Kiribati it does.•Conjunctival scarring is more common in adults in Kiribati than in Vanuatu.•Trachomatous inflammation—follicular lacks specificity f...